We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

228 hedge funds and large institutions have $4.71B invested in Amicus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 98 increasing their positions, 64 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $51.8M | Put options by funds: $11.3M

53% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 64

30% more capital invested

Capital invested by funds: $3.63B → $4.71B (+$1.08B)

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

10% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 29

9.28% more ownership

Funds ownership: 104.03% → 113.31% (+9.3%)

0% more funds holding

Funds holding: 228 → 228 (0)

Holders
228
Holders Change
–
Holders Change %
0%
% of All Funds
3.32%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.12%
New
32
Increased
98
Reduced
64
Closed
29
Calls
$51.8M
Puts
$11.3M
Net Calls
+$40.5M
Net Calls Change
+$36M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$181M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$87M
3
Deutsche Bank
Deutsche Bank
Germany
+$63.9M
4
JP Morgan Chase
JP Morgan Chase
New York
+$54.9M
5
Blackstone Inc
Blackstone Inc
New York
+$28M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$38.9M
2
BC
Boxer Capital
California
-$28.3M
3
RG
Redmile Group
California
-$24M
4
AG
Artal Group
Luxembourg
-$23.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$20.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
176
Los Angeles Capital Management
California
$184K – – –
OWP
177
Old Well Partners
North Carolina
$180K +$144K +12,700 New
OSAM
178
O'Shaughnessy Asset Management
Connecticut
$178K -$31K -2,726 -18%
PAS
179
Park Avenue Securities
New York
$177K +$22.3K +1,961 +19%
FB
180
Fulton Bank
Pennsylvania
$162K -$3.46K -305 -3%
Lazard Asset Management
181
Lazard Asset Management
New York
$162K +$5.05K +445 +4%
MYIA
182
Mount Yale Investment Advisors
Colorado
$158K +$693 +61 +0.6%
BWCS
183
Beirne Wealth Consulting Services
Connecticut
$155K +$124K +10,933 New
LCM
184
Legato Capital Management
California
$150K – – –
CA
185
Calton & Associates
Florida
$142K +$114K +10,011 New
Nisa Investment Advisors
186
Nisa Investment Advisors
Missouri
$108K +$363 +32 +0.4%
TLCM
187
Twin Lakes Capital Management
California
$85.1K – – –
PA
188
Parallel Advisors
California
$83.4K – – –
KBC Group
189
KBC Group
Belgium
$71K – – –
VanEck Associates
190
VanEck Associates
New York
$66K +$9.91K +873 +23%
EC
191
EntryPoint Capital
New York
$49.5K +$39.6K +3,489 New
FHA
192
First Horizon Advisors
Tennessee
$47.9K +$1.29K +114 +3%
AA
193
Ancora Advisors
Ohio
$38.2K – – –
C
194
Covestor
United Kingdom
$38K +$19.1K +1,686 +174%
NA
195
NewEdge Advisors
Louisiana
$27.3K +$15.2K +1,336 +228%
Carson Wealth (CWM LLC)
196
Carson Wealth (CWM LLC)
Nebraska
$24K -$556 -49 -3%
PFA
197
Pathway Financial Advisers
Indiana
$22.3K – – –
MLA
198
MB, Levis & Associates
Pennsylvania
$21.3K – – –
PNC Financial Services Group
199
PNC Financial Services Group
Pennsylvania
$20.9K +$2.21K +195 +15%
Daiwa Securities Group
200
Daiwa Securities Group
Japan
$16K – – –
6 7
8
9 10

FOLD Hedge Fund Activity: Q4 2023 in Review

228 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2023, worth a combined $4.71B — up 30% from $3.63B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new FOLD positions and 29 closed out — a net gain of 3 holders — while 98 added to existing stakes and 64 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $181M. The largest seller was Janus Henderson Group, cutting an estimated $38.9M.

  • 228 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $4.71B of Amicus Therapeutics stock for Q4 2023, up 30% quarter-over-quarter.
  • 32 funds opened new Amicus Therapeutics positions in Q4 2023 and 29 closed out, a net change of +3 holders.
  • The largest Amicus Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $181M added.
  • The largest Amicus Therapeutics seller in Q4 2023 was Janus Henderson Group, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2023.